602.90
Medpace Holdings Inc stock is traded at $602.90, with a volume of 219.12K.
It is down -2.84% in the last 24 hours and up +1.96% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$620.51
Open:
$624.86
24h Volume:
219.12K
Relative Volume:
0.79
Market Cap:
$16.83B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
37.93
EPS:
15.8963
Net Cash Flow:
$711.00M
1W Performance:
-3.09%
1M Performance:
+1.96%
6M Performance:
+21.55%
1Y Performance:
+13.69%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, NTRA, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings Inc
|
602.90 | 17.27B | 2.68B | 460.40M | 711.00M | 15.90 |
|
TMO
Thermo Fisher Scientific Inc
|
656.58 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
215.61 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
400.65 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
169.33 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
|
WAT
Waters Corp
|
436.43 | 42.59B | 3.77B | 449.25M | 240.68M | 7.8556 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-18-26 | Upgrade | TD Cowen | Sell → Hold |
| Feb-13-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-10-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance
UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673 - Moomoo
UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $673 From $405 - Moomoo
Enterprise value to EBIT forward of Medpace Holdings, Inc. – HAN:01P - TradingView
Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today - Benzinga
Insider Decision: August J Troendle Offloads $1.59M Worth Of Medpace Holdings Stock - Benzinga
Long term debt to total assets ratio of Medpace Holdings, Inc. – HAN:01P - TradingView
Medpace stock coverage resumed at UBS with neutral rating - Investing.com
UBS Initiates Coverage of Medpace (MEDP) with Neutral Rating and $673 Price Target - GuruFocus
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Medpace Holdings Insider Sold Shares Worth $1,589,941, According to a Recent SEC Filing - marketscreener.com
At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan
Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria
Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com
Medpace Holdings CEO August J. Troendle sells $6.75m in stock By Investing.com - Investing.com South Africa
Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com
Medpace Holdings CEO August Troendle sells $44.4m stock By Investing.com - Investing.com South Africa
Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Medpace Holdings Inc For: 26 September By Investing.com - Investing.com Canada
Medpace CEO August Troendle sells $27.4m in company stock - Investing.com
Medpace CEO August Troendle sells $27.4m in company stock By Investing.com - Investing.com South Africa
Form 4 Medpace Holdings Inc For: 26 September - Investing.com India
CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan
Medpace Holdings, Inc. (MEDP) Stock forecasts - uk.finance.yahoo.com
Insider Transaction: August J Troendle Sells $44.43M Worth Of Medpace Holdings Shares - Benzinga
Have Insiders Sold Medpace Holdings Shares Recently? - simplywall.st
After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan
Medpace stock falls 2.07 percent as CEO sale surfaces - AD HOC NEWS
Medpace(MEDP.US) 10% Shareholder Sells US$44.43 Million in Common Stock - moomoo.com
Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan
MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile
Mizuho maintains Outperform on Medpace, raises target to $586 - scanx.trade
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 - Investing News Network
Medpace Holdings Q3FY26 Results: Earnings call set for Oct 22 - scanx.trade
Medpace Holdings President & CEO Trades $6.75M In Company Stock - Benzinga
Projected EPS and Revenue Gains Might Change The Case For Investing In Medpace Holdings (MEDP) - Yahoo Finance
Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? - Yahoo Finance
Medpace Holdings Insider Sold Shares Worth $6,749,952, According to a Recent SEC Filing - moomoo.com
Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Medpace (NASDAQ:MEDP) CEO Sells $6,749,952.00 in Stock - MarketBeat
Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - Stock Titan
Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal
Medpace Holdings President & CEO Sold $15.36M In Company Stock - Benzinga
Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Connect - ACCESS Newswire
Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - Stock Titan
Medpace Holdings (MEDP) insider exercises 3,000 options - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Medpace (MEDP) Retreats -0.57%, Breaching $586.11 Support Line 2026-09-16Bearish Sentiment - careplusvn.com
Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP), Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Medpace Holdings Inc (MEDP) Stock Up 4.1% but GF Value Says Over - GuruFocus
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medpace Holdings Inc Stock (MEDP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Troendle August J. | President & CEO |
Sep 30 '26 |
Sale |
625.47 |
21,966 |
13,739,074 |
338,225 |
| Troendle August J. | President & CEO |
Sep 28 '26 |
Sale |
620.07 |
2,410 |
1,494,369 |
386,892 |
| Troendle August J. | President & CEO |
Sep 25 '26 |
Sale |
620.60 |
154 |
95,572 |
389,302 |
| Troendle August J. | President & CEO |
Sep 24 '26 |
Sale |
621.33 |
27,833 |
17,293,478 |
389,456 |
| Troendle August J. | President & CEO |
Sep 23 '26 |
Sale |
628.64 |
16,083 |
10,110,417 |
417,289 |
| Troendle August J. | President & CEO |
Sep 22 '26 |
Sale |
628.11 |
49,018 |
30,788,696 |
433,372 |
| Troendle August J. | President & CEO |
Sep 21 '26 |
Sale |
623.29 |
21,883 |
13,639,455 |
482,390 |
| Troendle August J. | President & CEO |
Sep 17 '26 |
Sale |
620.40 |
10,880 |
6,749,952 |
504,273 |
| Troendle August J. | President & CEO |
Sep 15 '26 |
Sale |
620.84 |
15,971 |
9,915,436 |
523,923 |
| Troendle August J. | President & CEO |
Sep 16 '26 |
Sale |
621.29 |
8,770 |
5,448,713 |
515,153 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):